Euprotec specialises in assessing the efficacy of your lead and candidate compounds in highly relevant and validated disease models.

Our models are well-suited to the development of multiple classes of agent including small molecules, natural products, peptides, antibodies and other biologics.

We provide a highly bespoke service, customising studies to meet you exact requirements based on the stage of your program and parameters/endpoints of interest.

Bacterial Infection

• Multiple sites of infection (localised and systemic).
• Gram positive (including Staphylococcus aureus, Streptococcus pneumoniae, and others).
• Gram negative (including Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumanii and others).
• Anaerobes (including Clostridium difficile).